Today: 19 April 2026
UOB share price slips into weekend: what investors watch next for United Overseas Bank stock
31 January 2026
1 min read

UOB share price slips into weekend: what investors watch next for United Overseas Bank stock

Singapore, Jan 31, 2026, 14:51 SGT — Market closed

United Overseas Bank shares dropped 1%, or S$0.38, closing at S$38.27 on Friday. The decline followed a 0.5% dip in Singapore’s Straits Times Index after Wall Street fell overnight. Rival banks DBS and OCBC also slipped, with 3,014,800 UOB shares changing hands.

The scene changed a day earlier when the Monetary Authority of Singapore held policy steady but raised its 2026 inflation outlook, flagging upside risks to both growth and inflation. Selena Ling described the update as “a tad more hawkish and less dovish.” Meanwhile, Chua Hak Bin at Maybank highlighted “simmering inflation pressures.” Unlike many central banks, MAS manages the Singapore dollar’s nominal effective exchange rate, or S$NEER, instead of a traditional policy rate—a framework that still influences funding costs and loan pricing. Reuters

The banking trio has been pushing the index up, with broker target prices climbing alongside. For UOB, the consensus target ticked up to S$37.26 from 16 analysts, despite the stock hitting a record high of S$39.50 late last week, The Business Times reported.

Friday’s pullback was slight, yet it nudged the stock away from recent peaks and back into an area where profit-taking usually kicks in fast. The percentage shifts are minor. Still, they carry weight since the banks lead the market action.

Next month’s earnings will take center stage. Investors will zero in on net interest margin, or NIM—the gap between what banks earn on loans versus what they pay on deposits—as well as fee income, provisions, and any remarks about loan demand in Southeast Asia.

DBS Group Research analyst Rui Wen Lim cautioned that it might be too soon to say asset-quality concerns are behind us, following UOB’s unusually large provisions in the September quarter. He noted the NIM decline is close to a “turning point” and predicted UOB and OCBC would deliver quarter-on-quarter gains in December. However, he also warned that non-interest income could soften after a strong third quarter. DBS Bank

As the market remains closed over the weekend, Monday’s open will take its lead from offshore signals — U.S. stocks, bond yields, and the prevailing risk sentiment. Singapore bank shares usually offer a stable corner of Asia’s equities but often move together sharply when volatility spikes.

UOB didn’t offer much in terms of new company updates over the weekend. So, it’s mostly about positioning, interest rates, and the lead-up to earnings that are driving the action.

UOB is set to release its full-year 2025 results on Feb. 24, before the market opens, according to a Singapore Exchange notice. Investors will be watching closely for any updates on margins and credit costs, which could influence the stock’s direction through late February.

Stock Market Today

  • 2 TSX Stocks Under $100 with Strong Upside Potential
    April 18, 2026, 9:56 PM EDT. CES Energy (TSX:CEU) and Bird Construction are two TSX-listed stocks priced below $100 that offer significant growth potential. CES Energy provides consumable chemical solutions to oil and gas producers, benefiting from rising service intensity and demand for advanced chemical treatments. Despite softer drilling activity, CES's revenue growth remains robust, supported by its asset-light model and strategic acquisitions. Macro trends like growing global energy demand and LNG infrastructure expansion further boost its outlook. Bird Construction, also trading under $100, stands out for its presence in the construction sector, which benefits from infrastructure spending and urban development. Both companies show disciplined capital allocation and resilient revenue drivers, making them attractive for investors seeking accessible entry points and potential capital appreciation on the TSX.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Paladin Energy share price dips as uranium jumps above $100 and a big holder exits the 5% line
Previous Story

Paladin Energy share price dips as uranium jumps above $100 and a big holder exits the 5% line

Keppel stock price slips into weekend — what investors are watching before Feb 5 results
Next Story

Keppel stock price slips into weekend — what investors are watching before Feb 5 results

Go toTop